Published • loading... • Updated
Morgan Stanley drops blunt verdict on Ozempic maker
Summary by BizToc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Morgan Stanley drops blunt verdict on Ozempic maker
Every blockbuster drug arrives with an expiration date attached, and anyone can read it years in advance. That makes pharmaceutical investing a strange business. The worst news about a company’s biggest product is almost never a surprise. It sits on a calendar, visible to everyone. So the fight…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
